| CYSB2400246 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-09-14 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400245 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-09-14 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400244 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-09-14 | | Anhui Anke Biotechnology (Group) Co Ltd | | | view |
| CYSB2400003 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-01-04 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2400002 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-01-04 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2400004 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2024-01-04 | | Changchun Lnstitute of Biological Products Co Ltd | | | view |
| CYSB2300186 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2023-10-19 | | Beijing Yuance Pharmaceutical Co Ltd | | | view |
| CYSB2300188 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2023-10-19 | | Beijing Yuance Pharmaceutical Co Ltd | | | view |
| CYSB2300187 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2023-10-19 | | Beijing Yuance Pharmaceutical Co Ltd | | | view |
| CYSB2000402 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000401 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000400 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-29 | 北京远策药业有限责任公司 | Beijing Yuance Pharmaceutical Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000356 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-18 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000355 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-18 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000354 | 注射用人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-12-18 | 长春生物制品研究所有限责任公司 | Changchun Lnstitute of Biological Products Co Ltd | In Review | 2022-01-27 | view |
| CYSB2000126 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-06-04 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-06-03 | view |
| CYSB2000125 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-06-04 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-06-03 | view |
| CYSB2000124 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2020-06-04 | 安徽安科生物工程（集团）股份有限公司 | Anhui Anke Biotechnology (Group) Co Ltd | In Review | 2020-06-03 | view |
| CYSB1600190 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2017-05-11 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2018-06-28 | view |
| CYSB1100254 | 注射用重组人干扰素α2b | Recombinant Human Interferon α2b | Lyophilized | Biological Products | Supplementary Application | 2011-11-01 | 北京凯因科技股份有限公司 | Beijing Kawin Technology Share-Holding Co Ltd | Certificate Issued | 2013-01-10 | view |
